Clinical Research Problem-Solving: How to Prepare for a Post-Pandemic World
Created by: Brian Lederman
Modified on: Mon, 8 Feb, 2021 at 1:38 PM
Current disruptions are increasing demand for business intelligence and causing sponsors and CROs to rethink their dependence on traditional business processes.
COVID-19 has disrupted clinical trials in many ways. Patients aren’t getting to sites. CRAs aren’t traveling. Physicians and medical staff aren’t as available to support trials. The FDA has issued emergency guidance for the pandemic, urging sponsors and CROs to find alternate ways of ensuring patient safety or give up their studies altogether.
Did you find it helpful?
Sorry we couldn't be helpful. Help us improve this article with your feedback.